CD314/NKG2D Monoklonaler Antikörper
CD314/NKG2D Monoklonal Antikörper für FC
Wirt / Isotyp
Maus / IgG1, kappa
Getestete Reaktivität
human
Anwendung
FC
Konjugation
Unkonjugiert
CloneNo.
1D11
Kat-Nr. : 65188-1-Ig
Synonyme
Geprüfte Anwendungen
Erfolgreiche Detektion in FC | humane PBMCs |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Produktinformation
65188-1-Ig bindet in FC CD314/NKG2D und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Maus / IgG1, kappa |
Klonalität | Monoklonal |
Typ | Antikörper |
Immunogen | NKL-Zelllinie |
Vollständiger Name | killer cell lectin-like receptor subfamily K, member 1 |
Berechnetes Molekulargewicht | 25 kDa |
GenBank-Zugangsnummer | BC039836 |
Gene symbol | KLRK1 |
Gene ID (NCBI) | 22914 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Mit Protein-A-Affinitätschromatographie gereinigt |
Lagerungspuffer | PBS with 0.09% sodium azide |
Lagerungsbedingungen | Store at 2-8°C. Stable for one year after shipment. |
Hintergrundinformationen
CD314, also known as NKG2D or Killer cell lectin-like receptor subfamily K member 1 (KLRK1), is a type II lectin-like transmembrane stimulatory receptor (PMID: 8436421). In humans, it is expressed on NK cells, gamma delta T cells, and CD8+ alpha beta T cells (PMID: 10426993). Various families of cell surface ligands have been identified, including the MICA/MICB and ULBP proteins (PMID: 12150888). CD314 is involved in both innate and adaptive immunities, and the NKG2D/NKG2DL pathway involves multiple effector cell types for controlling tumor progression (PMID: 31720075).
Protokolle
PRODUKTSPEZIFISCHE PROTOKOLLE | |
---|---|
FC protocol for CD314/NKG2D antibody 65188-1-Ig | Download protocol |
STANDARD-PROTOKOLLE | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |